---
schema_version: "secwatch.filing_event.v1"
accession: "0001860742-26-000086"
form_type: "8-K"
ticker: "BLCO"
cik: "0001860742"
company_name: "Bausch & Lomb Corp"
filed_at: "2026-07-29T11:02:15+00:00"
generated_at: "2026-07-29T11:05:10.061408+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Bausch + Lomb Q2 revenue $1.394B (+9% YoY); raises FY2026 guidance

## Summary
- Revenue $1.394B, up 9% reported and 8% constant currency YoY; GAAP net loss $14M vs $62M loss.
- Adjusted EBITDA $241M (+$50M YoY); Adjusted EBITDA ex-IPR&D $246M.
- Surgical revenue +19% (premium IOLs up 175%); Pharmaceuticals +15% (MIEBO/XIIDRA +27% H1).
- FY2026 revenue guidance raised to $5.44B-$5.54B; Adj. EBITDA ex-IPR&D raised to $1.025B-$1.075B.
- Cash flow from operations $153M, up from $35M; GAAP EPS ($0.04), adjusted EPS $0.15.

## SEC filing metadata
- accession: 0001860742-26-000086
- form_type: 8-K
- ticker: BLCO
- cik: 0001860742
- company_name: Bausch & Lomb Corp
- filed_at: 2026-07-29T11:02:15+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1860742/000186074226000086/0001860742-26-000086-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1860742/000186074226000086/blco-20260729.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001860742-26-000086
- JSON: https://secwatch.observer/filing/0001860742-26-000086.json
- Plain text: https://secwatch.observer/filing/0001860742-26-000086.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.